ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 631304 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 631304; 2) Community: the network communities that were significantly associated with the response to NSC 631304; 3) Molecule: the relationships between components within communities and NSC 631304; 4) MDR: the compounds that were significantly associated with the NSC 631304.

NSC Compound Enrichment Correlation
NSC 173516 1,3,5-Triazine-2,4-diamine, 1-[4-fluoro-3-(trifluoromethyl)phenyl]-1,6-dihydro-6,6-dimethyl-, monohydrochloride 0.0382675857669588 0.37029559
NSC 281383 Null 0.0382675857669588 0.26731172
NSC 36768 Null 0.0382675857669588 0.17502538
NSC 374028 Camptothecin Derivative 0.0382675857669588 0.59170663
NSC 53327 Null 0.0382675857669588 0.12762625
NSC 610458 Camptothecin Derivative 0.0382675857669588 0.59010117
NSC 619859 1H-3-Benzazepin-2-one, 2,3,4,5-tetrahydro-7,8-dimethoxy- 3-[(2,3-dimethoxyphenyl)methyl]-1-methylthio- 0.0382675857669588 0.17954718
NSC 623176 Null 0.0382675857669588 0.44045874
NSC 627168 2-[(3-N',N'-Dimethylamino)propyl]-9-methoxy-5-nitro-[6H]- pyrazolo[3,4,5-kl]acridine, free base 0.0382675857669588 0.27295033
NSC 628939 Null 0.0382675857669588 0.34232154
Total:64  Current:50    [First] [Prev] [Next] [Last]